Introduction
============

Lung cancer is one of the leading causes of cancer mortality worldwide.[@b1-cmar-10-4287] Non-small-cell lung cancer (NSCLC), the main type of lung cancer, accounts for 80%--85% of all cases, and small cell lung cancer (SCLC) accounts for around 20% of all cases. Although smoking is the major risk factor for lung cancer,[@b2-cmar-10-4287] only 7% of female patients with lung cancer have a history of cigarette smoking in Taiwan.[@b3-cmar-10-4287] In addition, other factors, such as environmental exposure[@b4-cmar-10-4287],[@b5-cmar-10-4287] or hereditary factors,[@b6-cmar-10-4287] have been reported in association with nonsmoking lung cancer patients. However, the molecular mechanisms of NSCLC among nonsmoking women are unclear, although some genes, such as EML4-ALK,[@b7-cmar-10-4287] EGFR,[@b8-cmar-10-4287] TP53,[@b9-cmar-10-4287] and PIK3CA,[@b10-cmar-10-4287] have been found to be associated with lung cancer in never smokers. Thus, it is important to explore the molecular mechanisms involved in NSCLC's onset and progression among nonsmoking females and identify effective biomarkers.

Recently, gene microarray and bioinformatics analysis were widely used to identify potential biomarkers of cancer. Interestingly, studies were performed to identify disease-related genes, which were associated with prognosis of breast cancer, by using integrated bioinformatics methods.[@b11-cmar-10-4287],[@b12-cmar-10-4287] Similarly, some studies were performed to find important key genes in lung cancer.[@b13-cmar-10-4287]--[@b15-cmar-10-4287] But there are limited studies on nonsmoking females with NSCLC.

In 2010, Lu et al[@b3-cmar-10-4287] obtained a panel of differentially expressed genes (DEGs) from nonsmoking female NSCLC patients and normal samples. Using the same data, the present study was performed to further screen the DEGs and predict their underlying function by functional and pathway enrichment analyses. Then, protein--protein interaction network (PPI) networks and modules of PPI network were performed to identify hub genes. More importantly, the prognostic values of the hub genes were further confirmed by survival analysis in nonsmoking females with NSCLC.

Materials and methods
=====================

Microarray data
---------------

Microarray expression profiles of GSE19804 were obtained from the Gene Expression Omnibus (GEO) database. GSE19804, which was based on the platform of the GPL570 (Affymetrix Human Genome U133 Plus 2.0 Array, Santa Clara, CA, USA), consisted of 60 samples from nonsmoking female NSCLC patients and 60 normal samples.[@b3-cmar-10-4287]

Identification of DEGs
----------------------

The DEGs between NSCLC samples and normal controls were identified using GEO2R (<https://www.ncbi.nlm.nih.gov/geo/geo2r/>), which is a web tool that is applied to screen DEGs by comparing two groups of samples. \|log FC\| \>1.5 and *P*\<0.01 were selected as the cutoff criterion.

Functional and pathway enrichment analysis
------------------------------------------

Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of DEGs were performed using Database for Annotation, Visualization, and Integrated Discovery (DAVID),[@b16-cmar-10-4287] which is a comprehensive set of functional annotation tools. *P*\<0.05 was set as the cutoff criterion.

PPI network analysis of DEGs and modules selection
--------------------------------------------------

The Search Tool for the Retrieval of Interacting Genes (STRING) database[@b17-cmar-10-4287] was used to construct a PPI network for DEGs. Then, the modules of PPI network with significant gene pairs (combined score \>0.8) was obtained by the Molecular Complex Detection (MCODE) plugin[@b18-cmar-10-4287] in Cytoscape.[@b19-cmar-10-4287] MCODE scores \>14 and the number of nodes \>15 were used as the cutoff values. Moreover, the function and pathway enrichment analysis of genes in each module was performed using DAVID.

Survival analysis of the hub genes
----------------------------------

Kaplan--Meier plotter is a web tool that predicts the prognostic values of genes in some cancer patients, including breast, ovarian, lung, and gastric cancer patients (<http://kmplot.com/analysis/index.php?p=background>). The nonsmoking female patients with NSCLC were divided into two groups according to the particular gene expression level (high vs low expression).[@b20-cmar-10-4287] Based on these categories, overall survival (OS) analysis of the two patient groups was then compared by the tool. The HR with 95% CIs and log-rank *P*-value were calculated and showed.

Results
=======

Identification of DEGs
----------------------

The total number of samples included 60 NSCLC samples and 60 normal samples. A total of 699 genes were identified, including 161 upregulated and 538 downregulated genes.

GO and KEGG pathway enrichment analysis
---------------------------------------

We used the DAVID for GO and KEGG pathway enrichment analysis based upon DEGs. The top five GO terms of DEGs are shown in [Table 1](#t1-cmar-10-4287){ref-type="table"}. As to biological process, the DEGs were significantly enriched in the regulation of cell proliferation, cell adhesion, biological adhesion, vasculature development, and blood vessel development. About cellular component, the DEGs were significantly enriched in the extracellular region part, extracellular region, extracellular space, cell surface, and proteinaceous extracellular matrix. In addition, the most enriched GO terms in molecular function were growth factor binding, carbohydrate binding, calcium ion binding, pattern binding, and polysaccharide binding. On the other hand, the most enriched KEGG pathway terms were as follows: ECM--receptor interaction, focal adhesion, cell adhesion molecules, neuroactive ligand-receptor interaction, and complement and coagulation cascades.

Construction of PPI network and module identification
-----------------------------------------------------

To predict the interactions of the identified DEGs from the protein level, a PPI network from STRING was constructed. In total, 439 nodes and 1,056 edges were shown in the PPI network ([Figure 1](#f1-cmar-10-4287){ref-type="fig"}). The subset of PPI network for the DEGs with a combined score \>0.8 was performed to determine the hub genes. The top 15 genes were selected as hub genes, which were GNG11, UBE2C, CCNB2, NMU, ANXA1, FPR2, KIF20A, MELK, NUSAP1, DLGAP5, CENPF, BIRC5, TOP2A, TPX2, and HMMR ([Table 2](#t2-cmar-10-4287){ref-type="table"}). Subsequently, two modules with MCODE scores \>14 and the number of nodes \>15 were selected ([Figure 2](#f2-cmar-10-4287){ref-type="fig"}), and enrichment analysis showed that the genes in the modules were mainly associated with cell cycle, chemokine signaling pathway, cytokine-cytokine receptor interaction, and neuroactive ligand-receptor interaction ([Table 3](#t3-cmar-10-4287){ref-type="table"}).

Survival analysis
-----------------

Kaplan--Meier plotter was used to predict the prognostic value of 15 identified hub genes. Our results showed that high expression of UBE2C was associated with worse OS for NSCLC patients, as well as DLGAP5, TPX2, CCNB2, BIRC5, KIF20A, and TOP2A (*P*\<0.05) ([Figure 3](#f3-cmar-10-4287){ref-type="fig"}). Additionally, low expression of ANXA1 was associated with poorer OS for NSCLC patients, as well as GNG11 (*P*\<0.05) ([Figure 3](#f3-cmar-10-4287){ref-type="fig"}).

Discussion
==========

In this study, a total of 699 DEGs were screened, including 161 upregulated genes and 538 downregulated genes. Moreover, we selected two significant modules with several key DEGs in the regulatory network of nonsmoking female patients with NSCLC. Then, survival analysis of these genes determined that seven overexpressed genes (UBE2C DLGAP5, TPX2, CCNB2, BIRC5, KIF20A, and TOP2A) and two downregulated genes (GNG11 and ANXA1) were significantly correlated with worse OS of nonsmoking female patients with NSCLC.

The data showed that the seven overexpressed genes are involved in "module 1" of the subnetwork, which is enriched in the cell cycle pathway. As we know that, ubiquitin-conjugating enzyme E2C (UBE2C) is a key regulator of cell cycle progression. High expression of UBE2C is associated with aggressive progression and poor outcome of malignant glioma,[@b21-cmar-10-4287] and UBE2C has been identified as a prognostic protein marker in bladder cancer.[@b22-cmar-10-4287] Moreover, UBE2C, DLGAP5, and TPX2 are associated with the progression and prognosis of pancreatic carcinoma.[@b23-cmar-10-4287] Additionally, both DLGAP5 and TPX2 are mitosis-associated genes and correlated with poor prognosis in NSCLC patients.[@b24-cmar-10-4287] TPX2 overexpression is associated with poor survival in gastric cancer.[@b25-cmar-10-4287] A study also found that TPX2 promotes glioma cell proliferation and invasion via activation of the AKT signaling pathway in glioblastoma multiforme.[@b26-cmar-10-4287] Elevated DLGAP5 expression was negatively correlated with both OS and relapse-free survival of lung cancer.[@b27-cmar-10-4287] A study found that silencing of DLGAP5 by siRNA significantly inhibits the proliferation and invasion of hepatocellular carcinoma cells.[@b28-cmar-10-4287] Cyclin B2 (CCNB2) is a member of cyclin family proteins. Using the same data (GEO:GSE19804), Qian et al further demonstrated that both mRNA and protein expressions of CCNB2 were higher in NSCLC than in normal lung tissues and CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients.[@b29-cmar-10-4287] BIRC5, which codes for survivin, can participate in cellular survival functions, such as cell cycle progression.[@b30-cmar-10-4287] Moreover, BIRC5 (survivin) is a pejorative prognostic marker in stage II/III breast cancer.[@b31-cmar-10-4287] Similarly, survivin is upregulated in lung cancer tissues and high expression of BIRC5 is associated with poor survival in lung cancer.[@b32-cmar-10-4287],[@b33-cmar-10-4287] Kinesin family member 20A (KIF20A), also known as RAB6KIFL, plays an important role in cytokinesis.[@b34-cmar-10-4287] In addition, it has been reported that high expression of KIF20A is associated with poor OS in cervical squamous cell carcinoma.[@b35-cmar-10-4287] Similarly, a study has found that positive expression of KIF20A indicates poor prognosis of glioma patients.[@b36-cmar-10-4287] High expression of TOP2A, which is involved in DNA synthesis and transcription, is associated with recurrence and metastasis of prostate cancer.[@b37-cmar-10-4287] In addition, high mRNA levels of TOP2A are independent predictors of poor outcome in renal cell carcinoma patients.[@b38-cmar-10-4287] Moreover, another study has found that TOP2A is associated with worse prognosis in NSCLC patients.[@b39-cmar-10-4287] Taken together, these data suggest that UBE2C, DLGAP5, TPX2, CCNB2, BIRC5, KIF20A, and TOP2A are involved in the cell cycle pathway and play a significant role in cancer development, which supports our findings.

On the other hand, GNG11 and ANXA1, which are found in "module 2", were associated with chemokine signaling pathway, cytokine-cytokine receptor interaction, and neuroactive ligand-receptor interaction. GNG11, a lipid-anchored protein, acts as a tumor suppressor in lung adenocarcinoma.[@b40-cmar-10-4287] Annexin A1 (ANXA1) is a calcium- and phospholipid-binding protein. Some studies found that low ANXA1 expression was associated with better OS in gastric cancer[@b41-cmar-10-4287] and esophageal squamous cell carcinoma.[@b42-cmar-10-4287] However, low expression of ANXA1 was correlated with worse OS in breast cancer patients.[@b43-cmar-10-4287] Downregulation of ANXA1 is correlated with radioresistance in nasopharyngeal carcinoma.[@b44-cmar-10-4287] Moreover, decreased expression of ANXA1 was correlated with poor survival of pancreatic ductal adenocarcinoma (PDAC) patients, and ANXA1 knockdown inhibited cell proliferation, induced G1 phase cell cycle arrest, and increased PDAC cell migration and invasion capacity compared with controls.[@b45-cmar-10-4287] Similarly, ANXA1 knockdown suppressed the proliferation, migration, and invasion of NSCLC cells.[@b46-cmar-10-4287] Together, we speculate that GNG11 and ANXA1 may play a crucial role in NSCLC. ANXA1 could regulate the gastric cancer cell invasion through the formyl peptide receptor (FPR)/extracellular signal-regulated kinase/integrin beta-1-binding protein pathway, and all three FPRs (FPR1 through FPR3) were involved in the regulation process.[@b41-cmar-10-4287] FPR2 promotes invasion and metastasis of gastric cancer cells and predicts the prognosis of patients.[@b47-cmar-10-4287] A study also found that FPR2 was overexpressed in epithelial ovarian cancer (EOC) tissues and FPR2 overexpression indicated poor prognosis of EOC patients.[@b48-cmar-10-4287] However, in the present study, we found that FPR2 was downregulated and low expression indicated better prognosis of NSCLC patients. Similarly, we found that Neuromedin U (Nmu), a secreted neuropeptide, was upregulated and high expression indicated better prognosis of NSCLC patients. But in HNSCC, the expression levels of Nmu in primary tumors with regional metastasis were higher, compared with those without metastasis, and overexpression of Nmu may be involved in the process of regional metastasis of HNSCC.[@b49-cmar-10-4287] So, the roles of FPR2 and Nmu need to be further investigated.

In summary, the present study was intended to identify the potential biomarkers and analyze the prognostic values in nonsmoking females with NSCLC by bioinformatics analysis. We found that hub genes of complex networks, such as UBE2C, DLGAP5, TPX2, CCNB2, BIRC5, KIF20A, TOP2A, GNG11, and ANXA1, may act as potential biomarkers for nonsmoking females with NSCLC. However, the current study was performed by bioinformatics analysis and the conclusions remain to be confirmed by corresponding experiments. Therefore, further investigation is required to verify our findings and determine the potential clinical value of these as biomarkers.
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![The two modules identified in the PPI network of the DEGs.\
**Note:** (**A**) Module 1 and (**B**) module 2. Blue represents upregulated DEGs; yellow represents downregulated DEGs.\
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###### 

Functional and pathway enrichment analysis of DEGs in nonsmoking females with NSCLC

                   ID                                        Description                        Count      *P*-value
  ---------------- ----------------------------------------- ---------------------------------- ---------- -----------
                                                                                                           
  GO_function      GO-BP:0042127                             Regulation of cell proliferation   55         2.29E-10
  GO-BP:0007155    Cell adhesion                             51                                 2.94E-10   
  GO-BP:0022610    Biological adhesion                       51                                 3.04E-10   
  GO-BP:0001944    Vasculature development                   28                                 1.03E-09   
  GO-BP:0001568    Blood vessel development                  27                                 2.83E-09   
  GO-CC:0044421    Extracellular region part                 87                                 5.32E-22   
  GO-CC:0005576    Extracellular region                      130                                2.84E-20   
  GO-CC:0005615    Extracellular space                       61                                 8.88E-15   
  GO-CC:0009986    Cell surface                              36                                 1.30E-10   
  GO-CC:0005578    Proteinaceous extracellular matrix        33                                 9.70E-10   
  GO-MF:0019838    Growth factor binding                     15                                 6.47E-07   
  GO-MF:0030246    Carbohydrate binding                      27                                 2.57E-06   
  GO-MF:0005509    Calcium ion binding                       48                                 8.91E-06   
  GO-MF:0001871    Pattern binding                           16                                 1.39E-05   
  GO-MF:0030247    Polysaccharide binding                    16                                 1.39E-05   
  KEGG\_ PATHWAY   hsa04512                                  Ecm-receptor interaction           16         3.74E-08
  hsa04510         Focal adhesion                            16                                 0.001596   
  hsa04514         CAMs                                      11                                 0.008625   
  hsa04080         Neuroactive ligand-receptor interaction   16                                 0.014903   
  hsa04610         Complement and coagulation cascades       7                                  0.021259   

**Note:** Top five terms were selected according to *P*-value.

**Abbreviations:** BP, biological process; CAMs, cell adhesion molecules; CC, cellular component; DEGs, differentially expressed genes; ECM, extracellular matrix; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; MF, molecular function; NSCLC, non-small-cell lung cancer.

###### 

The hub genes that had a degree \>20 in PPI network

  Gene     Regulation   Degree
  -------- ------------ --------
                        
  GNG11    Down         29
  UBE2C    Up           28
  CCNB2    Up           23
  NMU      Up           22
  ANXA1    Down         22
  FPR2     Down         22
  KIF20A   Up           22
  MELK     Up           21
  NUSAP1   Up           21
  DLGAP5   Up           21
  CENPF    Up           21
  BIRC5    Up           21
  TOP2A    Up           21
  TPX2     Up           21
  HMMR     Up           21

**Abbreviation:** PPI, protein--protein interaction.

###### 

Functional and pathway enrichment analysis of the DEGs in modules

                 ID           Description                                            Count   *P*-value
  -------------- ------------ ------------------------------------------------------ ------- -------------
                                                                                             
  Module 1                                                                                   
  GO_BP          GO:0000280   Nuclear division                                       13      4.29E-18
  GO_BP          GO:0007067   Mitosis                                                13      4.29E-18
  GO_BP          GO:0000087   M phase of mitotic cell cycle                          13      5.34E-18
  GO_BP          GO:0000279   M phase                                                14      6.27E-18
  GO_BP          GO:0048285   Organelle fission                                      13      6.99E-18
  GO_CC          GO:0015630   Microtubule cytoskeleton                               14      3.15E-14
  GO_CC          GO:0005819   Spindle                                                10      2.30E-13
  GO_CC          GO:0044430   Cytoskeletal part                                      14      3.57E-11
  GO_CC          GO:0005856   Cytoskeleton                                           15      1.91E-10
  GO_CC          GO:0043232   Intracellular non-membrane- bounded organelle          16      6.69E-08
  GO_MF          GO:0005524   ATP binding                                            9       2.60E-04
  GO_MF          GO:0032559   Adenyl ribonucleotide binding                          9       2.85E-04
  GO_MF          GO:0030554   Adenyl nucleotide binding                              9       4.10E-04
  GO_MF          GO:0001883   Purine nucleoside binding                              9       4.56E-04
  GO_MF          GO:0001882   Nucleoside binding                                     9       4.78E-04
  KEGG_PATHWAY   hsa04110     Cell cycle                                             3       0.008428591
  Module 2                                                                                   
  GO_BP          GO:0006935   Chemotaxis                                             8       4.59E-11
  GO_BP          GO:0007186   G-protein coupled receptor protein signaling pathway   12      8.22E-11
  GO_BP          GO:0007166   Cell surface receptor linked signal transduction       13      4.90E-10
  GO_BP          GO:0006954   Inflammatory response                                  6       8.52E-06
  GO_BP          GO:0006955   Immune response                                        7       2.17E-05
  GO_CC          GO:0005615   Extracellular space                                    5       0.003963123
  GO_CC          GO:0044421   Extracellular region part                              5       0.013058837
  GO_CC          GO:0005576   Extracellular region                                   6       0.040928448
  GO_MF          GO:0008009   Chemokine activity                                     5       9.63E-08
  GO_MF          GO:0042379   Chemokine receptor binding                             5       1.25E-07
  GO_MF          GO:0005125   Cytokine activity                                      5       3.17E-05
  GO_MF          GO:0001653   Peptide receptor activity                              4       1.77E-04
  GO_MF          GO:0008528   Peptide receptor activity, G-protein coupled           4       1.77E-04
  KEGG_PATHWAY   hsa04062     Chemokine signaling pathway                            7       9.05E-07
  KEGG_PATHWAY   hsa04060     Cytokine-cytokine receptor interaction                 6       1.25E-04
  KEGG_PATHWAY   hsa04080     Neuroactive ligand-receptor interaction                5       0.001563563

**Abbreviations:** BP, biological process; CC, cellular component; DEGs, differentially expressed genes; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; MF, molecular function.
